From scientific excellence to competitive innovation: How Europe is strengthening its life sciences translation power

Europe’s science is strong. Yet, when seeing the resources allocated and cultural forces leveraged by other international giants, such as the US and China, for their economic competitiveness in life sciences, it is not uncommon for Europe to also be experienced as slow to bring innovation to market. Structural orchestration for asset framing and value-creation pathways, aligned timings and funding for maturation, or friction between sectors drivers are all parts of the knot stakeholders continuously try to disentangle moving forward. European players haven’t said their last word, though. Speakers will discuss the ways Europe is already – and can further – strengthen its translation pathways to keep a competitive edge, as well as how our life sciences power can find its right place on the international stage, leveraging other players’ strengths its way.